Pulmonx Corporation Common Stock

LUNG Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of LUNG by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
LUNG Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
LUNG Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
LUNG Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in LUNG holdings by institutional investors

Insider Trading

Quarterly net insider trading by LUNG's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
Corporate Lobbying

LUNG Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
Revenue Breakdown

LUNG Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
LUNG Income Statement
LUNG Balance Sheet
LUNG Cash Flow
U.S. Patents

New LUNG patent grants

  • Patent Title: Systems and methods for endobronchial diagnostics Nov. 18, 2025
  • Patent Title: Methods and systems for endobronchial diagnostics Nov. 11, 2025
  • Patent Title: Methods and systems for endobronchial diagnosis Jul. 22, 2025
  • Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Jul. 08, 2025
  • Patent Title: Collateral flow channel sealant delivery methods and systems May. 27, 2025
  • Patent Title: Implant loading device and system Aug. 20, 2024
  • Patent Title: Methods, systems, and devices for analyzing lung imaging data to determine collateral ventilation Jul. 09, 2024
  • Patent Title: Devices and systems for lung treatment Jul. 09, 2024
  • Patent Title: Methods, systems, and devices for analyzing lung imaging data Jun. 11, 2024
  • Patent Title: Measuring lung function and lung disease progression at a lobar/segmental level Mar. 26, 2024
  • Patent Title: Functional assessment and treatment catheters and methods for their use in the lung Mar. 19, 2024
  • Patent Title: Methods and systems for determining collateral ventilation Feb. 27, 2024
  • Patent Title: Lung volume reduction therapy using crosslinked non-natural polymers Jun. 19, 2018
  • Patent Title: Implant loading device and system Jan. 23, 2018
  • Patent Title: Devices and systems for lung treatment Mar. 14, 2017
  • Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Jan. 03, 2017
  • Patent Title: Selective lung tissue ablation Nov. 08, 2016
  • Patent Title: Functional assessment and treatment catheters and methods for their use in the lung Sep. 13, 2016
  • Patent Title: Methods and systems for endobronchial diagnosis Jun. 14, 2016
  • Patent Title: Implant loading device and system Dec. 15, 2015
  • Patent Title: Pulmonary occlusal stent delivery catheter, loading system and methods of use Sep. 15, 2015
  • Patent Title: Measuring lung function and lung disease progression at a lobar/segmental level Aug. 18, 2015
  • Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Jun. 09, 2015
  • Patent Title: Collateral pathway treatment using agent entrained by aspiration flow current Nov. 04, 2014
  • Patent Title: Methods and systems for endobronchial diagnostics Aug. 19, 2014
  • Patent Title: Selective lung tissue ablation Oct. 29, 2013
  • Patent Title: Minimally invasive determination of collateral ventilation in lungs Sep. 03, 2013
  • Patent Title: Methods and devices for passive residual lung volume reduction and functional lung volume expansion Jul. 30, 2013
  • Patent Title: Implanted bronchial isolation devices and methods Jul. 02, 2013
  • Patent Title: Minimally invasive determination of collateral ventilation in lungs Jun. 04, 2013
  • Patent Title: Pulmonary occlusal stent delivery catheter, loading system and methods of use Apr. 02, 2013
  • Patent Title: Bronchial flow control devices and methods of use Mar. 05, 2013
  • Patent Title: Methods and devices for use in performing pulmonary procedures Jan. 22, 2013
  • Patent Title: Functional assessment and treatment catheters and methods for their use in the lung Jan. 01, 2013
  • Patent Title: Bronchial flow control devices with membrane seal Aug. 28, 2012
  • Patent Title: Methods and devices for blocking flow through collateral pathways in the lung Jun. 26, 2012
  • Patent Title: Methods, systems, and kits for lung volume reduction May. 15, 2012
  • Patent Title: Methods and systems for occluding collateral flow channels in the lung Mar. 20, 2012
  • Patent Title: Methods and devices to induce controlled atelectasis and hypoxic pulmonary vasoconstriction Mar. 20, 2012
  • Patent Title: Occlusion device Mar. 20, 2012
  • Patent Title: Loading device for a pulmonary implant Jan. 24, 2012
  • Patent Title: Minimally invasive determination of collateral ventilation in lungs Feb. 08, 2011
  • Patent Title: Bronchial flow control devices and methods of use Dec. 21, 2010
  • Patent Title: Delivery methods and devices for implantable bronchial isolation devices Oct. 19, 2010
  • Patent Title: Bronchial flow control devices with membrane seal Sep. 21, 2010
  • Patent Title: Bronchial flow control devices and methods of use Aug. 10, 2010
  • Patent Title: Methods, systems, and kits for lung volume reduction Aug. 03, 2010
  • Patent Title: Delivery methods and devices for implantable bronchial isolation devices May. 18, 2010
  • Patent Title: Occlusion device Mar. 02, 2010
  • Patent Title: Methods and devices for use in performing pulmonary procedures Feb. 16, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to LUNG from public contracts

LUNG News

Recent insights relating to LUNG

CNBC Recommendations

Recent picks made for LUNG stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LUNG

LUNG Analyst Ratings

LUNG Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
LUNG Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $LUNG stock a Buy, Sell, or Hold?

  • What is the price target for $LUNG stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

LUNG Top Shareholders
Shareholder
Shares Held
LUNG Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $LUNG stock?

  • Who owns the most shares of $LUNG stock?

  • What funds own $LUNG stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

LUNG Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view LUNG Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About LUNG

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

  • Address Redwood City, CA
  • Market Cap 67.2 million
  • Employees 291
  • Industrial Classification Surgical & Medical Instruments & Apparatus
Back To Top